Similar articles for PMID: 29488184

Year	Number of Results
1979	1
2004	1
2005	1
2006	1
2007	1
2008	8
2009	5
2010	5
2011	10
2012	14
2013	20
2014	12
2015	20
2016	16
2017	23
2018	33
2019	34
2020	34
2021	47
2022	34
2023	24
2024	0

1

Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.

Darlix A, Griguolo G, Thezenas S, Kantelhardt E, Thomssen C, Dieci MV, Miglietta F, Conte P, Braccini AL, Ferrero JM, Bailleux C, Jacot W, Guarneri V. Darlix A, et al. J Neurooncol. 2018 Jun;138(2):369-382. doi: 10.1007/s11060-018-2805-9. Epub 2018 Feb 27. J Neurooncol. 2018. PMID: 29488184

2

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.

Anders CK, Deal AM, Miller CR, Khorram C, Meng H, Burrows E, Livasy C, Fritchie K, Ewend MG, Perou CM, Carey LA. Anders CK, et al. Cancer. 2011 Apr 15;117(8):1602-11. doi: 10.1002/cncr.25746. Epub 2010 Nov 29. Cancer. 2011. PMID: 21472708 Free PMC article.

3

De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.

Press DJ, Miller ME, Liederbach E, Yao K, Huo D. Press DJ, et al. Clin Exp Metastasis. 2017 Dec;34(8):457-465. doi: 10.1007/s10585-017-9871-9. Epub 2017 Dec 29. Clin Exp Metastasis. 2017. PMID: 29288366

4

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.

Bae SY, Kim S, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ. Bae SY, et al. BMC Cancer. 2015 Mar 18;15:138. doi: 10.1186/s12885-015-1121-4. BMC Cancer. 2015. PMID: 25880075 Free PMC article.

5

Impact of triple negative phenotype on breast cancer prognosis.

Kaplan HG, Malmgren JA. Kaplan HG, et al. Breast J. 2008 Sep-Oct;14(5):456-63. doi: 10.1111/j.1524-4741.2008.00622.x. Epub 2008 Jul 24. Breast J. 2008. PMID: 18657139

6

Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.

Shen Q, Sahin AA, Hess KR, Suki D, Aldape KD, Sawaya R, Ibrahim NK. Shen Q, et al. Oncologist. 2015 May;20(5):466-73. doi: 10.1634/theoncologist.2014-0107. Epub 2015 Mar 23. Oncologist. 2015. PMID: 25802405 Free PMC article.

7

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.

Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, de Boer M, Borm GF, Tjan-Heijnen VC. Lobbezoo DJ, et al. Breast Cancer Res Treat. 2013 Oct;141(3):507-14. doi: 10.1007/s10549-013-2711-y. Epub 2013 Oct 9. Breast Cancer Res Treat. 2013. PMID: 24104881

8

Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.

Leone JP, Leone J, Zwenger AO, Iturbe J, Leone BA, Vallejo CT. Leone JP, et al. Eur J Cancer. 2017 Mar;74:17-25. doi: 10.1016/j.ejca.2016.12.015. Epub 2017 Feb 6. Eur J Cancer. 2017. PMID: 28335884

9

Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.

Poorolajal J, Nafissi N, Akbari ME, Mahjub H, Esmailnasab N, Babaee E. Poorolajal J, et al. Arch Iran Med. 2016 Oct;19(10):680-686. Arch Iran Med. 2016. PMID: 27743431

10

Prognostic impact of breast cancer subtypes in elderly patients.

Bergen ES, Tichy C, Berghoff AS, Rudas M, Dubsky P, Bago-Horvath Z, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R. Bergen ES, et al. Breast Cancer Res Treat. 2016 May;157(1):91-9. doi: 10.1007/s10549-016-3787-y. Epub 2016 Apr 23. Breast Cancer Res Treat. 2016. PMID: 27107570 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

301 results

Results by year